Herlev Hospital
328
43
58
187
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.1%
20 terminated/withdrawn out of 328 trials
90.3%
+3.8% vs industry average
11%
37 trials in Phase 3/4
6%
11 of 187 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (328)
Conservative Treatment or Resuturing Among Women With Perineal Wound Dehiscence After Vaginal Labour
Role: lead
Zinc Supplementation and Inflammation in Older Medical Patients
Role: lead
Treatment of Peyronie's Disease With Platelet-Rich Plasma
Role: lead
Platelet-Rich Plasma for Peyronie's Disease
Role: lead
Cancer of the Prostate Treated With Focal Implantation of a RadioactivE Source
Role: lead
The CPH-MBD Cohort
Role: lead
Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance
Role: lead
Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance
Role: lead
The Effect of Reduced Bleomycin in Electrochemotherapy Treatment
Role: collaborator
Prophylactic Antibiotic Treatment in Hemodialysis
Role: collaborator
Molecularly Tailored Therapy in Advanced Pancreatic Cancer
Role: lead
A Study of Population and Sex-specific Troponin Cutoffs for Ruling Out Acute Myocardial Infarction
Role: lead
Cardiac Arrhythmia in Patients With End-Stage Renal Disease
Role: collaborator
DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart Failure
Role: collaborator
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
Role: collaborator
Accelerated Treatment of Endocarditis
Role: lead
Accelerated Treatment of Endocarditis
Role: collaborator
Effect of Intensive Nutrition Training, Education, and Support in Gestational Diabetes - The INTENSE-GDM TRIAL
Role: collaborator
When to INDuce for OverWeight? (WINDOW)
Role: collaborator
Dermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology Experts
Role: lead